Telo Genomics Corp
XTSX:TELO
Telo Genomics Corp
XTSX:TELO
Price:
0.05
CAD
Market Closed
Market Cap:
CA$5m
Balance Sheet
Balance Sheet Decomposition
Telo Genomics Corp
Telo Genomics Corp
Balance Sheet Decomposition is not available for
Telo Genomics Corp
Telo Genomics Corp
Balance Sheet
Telo Genomics Corp
Telo Genomics Corp
Currency: CAD
| Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
0
|
1
|
4
|
3
|
1
|
|
| Cash |
0
|
1
|
0
|
0
|
1
|
4
|
0
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
2
|
0
|
0
|
1
|
4
|
3
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
3
+246%
|
0
-86%
|
0
-39%
|
1
+345%
|
4
+229%
|
3
-26%
|
1
-68%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-20%
|
1
-16%
|
1
+76%
|
0
-70%
|
0
-61%
|
0
+50%
|
0
+72%
|
|
| Equity | |||||||||
| Common Stock |
1
|
10
|
11
|
12
|
14
|
18
|
19
|
25
|
|
| Retained Earnings |
2
|
12
|
17
|
18
|
19
|
20
|
22
|
31
|
|
| Additional Paid In Capital |
1
|
4
|
5
|
5
|
6
|
6
|
6
|
6
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
2
N/A
|
0
N/A
|
1
-233%
|
1
N/A
|
4
+375%
|
3
-29%
|
1
-80%
|
|
| Total Liabilities & Equity |
1
N/A
|
3
+246%
|
0
-86%
|
0
-39%
|
1
+345%
|
4
+229%
|
3
-26%
|
1
-68%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
11
|
13
|
13
|
41
|
56
|
59
|
100
|
|
Switch to:
Switch to:
See Also
Discover More
